Tiers Lieu : INTERCEPTION
Supported by : Gustave Roussy
Main consortium members : UNICANCER, Cancer Contributions, center Léon Bérard, CEGEDIM, ODYSSEA, CPTS de la Bièvre, CPTS OCTAV, CPTS Val de Bièvre, CRCDC Ile-de-France, DAC 94, ELSAN
The Tiers Lieu INTERCEPTION supports the personalized prevention healthcare pathway for people at high risk of cancer. It creates a mixed infrastructure (digital and physical, city-hospital) enabling new screening and prevention methods for these people to be developed and tested under real conditions, using digital solutions.
40%
of people with a cancer diagnosis could be identified as high risk in the previous 5 to 10 years
.The Tiers Lieu service offering
Gustave Roussy's Tiers Lieu Interception has a mixed clinical and research/innovation vocation: it identifies people at increased risk of cancer in France and offers them personalized prevention and screening as part of a city-hospital collaboration and a largely paperless infrastructure.
Its digital infrastructure (MyInterception® application) combined with a national EDS also enable the development or validation of new early detection and cancer risk reduction solutions, in particular using digital solutions.
MyInterception is a multifunctional digital platform, centered on a patient portal, enabling the collection and storage of personalized prevention data, the implementation of the personal prevention program, and the interface with healthcare professionals.
The web portal for healthcare professionals will provide access to cancer prevention research programs.
Tiers lieu projects
Project 1: Cross-Prev, automated identification of people at high risk of cancer by their GPs
Supplier : CEGEDIM
Solution : A new function developed in the Crossway® practice management software used by private practitioners and Maiia® the digital assistance for booking appointments and communication between caregivers.
Experimentation with 50 volunteer liberal physicians equipped with the Cegedim software suite (Crossway with PLCOm2012noRace + Maiia + THIN®) in Ile de France.
Need: To systematically and rapidly identify people at high risk of lung cancer who could benefit from referral to the Interception program and/or the new Impulsion lung cancer screening program, which sees the light of day in January 2026.
Tiers-Lieu's contribution: Tiers Lieu has enabled the joint development of this new software solution and its real-life testing with healthcare professionals
- The first innovation lies in the integration of the validated lung cancer risk assessment score PLCOm2012noRace into the Crossway practice management software used by thousands of independent doctors.
- The second innovation lies in the direct and rapid referral to the INTERCEPTION program of patients who accept the treatment proposed by their doctor, through Maiia (digital assistance for booking appointments and communication between caregivers).
Project 2: Scorisk4all, validation of a self-questionnaire enabling healthcare professionals to identify high-risk cancer situations
The Scorisk4all study aimsto evaluate the relevance of the ScoRisk-4-all self-questionnaire, subsequently enabling faster assessment of high-risk situations by healthcare professionals.
Supplier: Gustave Roussy
Solution : an online self-questionnaire allowing people to pre-fill in items that will then enable healthcare professionals to reliably and quickly identify people at high risk of cancer
Need : It is essential to develop software solutions featuring self-questionnaires combined with risk assessment algorithms, as part of the national Interception program (article 51) but also as part of the national roll-out of Mon Bilan Prévention. Pre-filling self-questionnaires, once validated, will save healthcare professionals a great deal of time
Tiers Lieu's contribution: co-developing self-questionnaires with the help of patient associations and professionals, and conducting the validation of these self-questionnaires
Project 3: My INTERCEPTION follow-up, digital and interactive
Supplier : SANTELIEN and ALIRA HEALTH, development and configuration deployment and testing with Tiers Lieu partners including user associations.
Solution : industrialization of the MyInterception platform and interoperability with existing care coordination platforms (Santélien) and with Mon Espace Santé
Need: personalized cancer prevention requires coordination and fluid interactions between healthcare professionals and participants
Tiers Lieu contribution: development and creation of connected interoperability with industry players
Key project dates
- February 17, 2023: kick off of Tiers Lieu Interception
- July 4, 2023: start of project 1
- May 2024: start of project 2
- July 2025: preparation of final report for project 1
- September 2025: start of project 3
- January 2026: preparation of final report for project 2